Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers
Crossref DOI link: https://doi.org/10.1007/s10549-016-3800-5
Published Online: 2016-04-25
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paluch-Shimon, Shani
Friedman, Eitan
Berger, Raanan
Papa, Moshe
Dadiani, Maya
Friedman, Neil
Shabtai, Moshe
Zippel, Dov
Gutman, Mordechai
Golan, Talia
Yosepovich, Ady
Catane, Raphael
Modiano, Tami
Kaufman, Bella
Text and Data Mining valid from 2016-04-25